At KBI Biopharma, we work closely with our clients to deliver fully integrated drug development and biologics manufacturing services. Built on world-class analytics capabilities and deep technical expertise in mammalian systems, we partner with you to develop robust cell lines, optimize processes, and advance your programs from early development through commercial scale.
We are delighted to announce our participation in DCAT Week 2026, and we are looking forward to networking, sharing industry insights, and learning from fellow thought leaders in the biopharmaceutical business.
Meet with the KBI Biopharma Team:
About KBI Biopharma:
KBI Biopharma is a leading global contract development and manufacturing organization (CDMO) providing fully integrated, accelerated drug development and biologics manufacturing services and expertise to life science companies. With each of our 1400+ client partners, we work closely to personalize and accelerate drug development programs. Built upon a foundation of world-class analytics capabilities and extensive scientific and technical expertise, we deliver robust process development and clinical and commercial cGMP manufacturing services for mammalian and microbial programs. Recognized for quality manufacturing, we help clients advance drug candidates into the clinic and beyond.
Learn more about KBI Biopharma >>
DCAT Week is the premier global event held annually in New York City for companies engaged in the biopharmaceutical business ecosystem. It is hosted by the Drug, Chemical & Associated Technologies Association (DCAT), a not-for-profit, corporate member-supported, and volunteer-led organization dedicated to fostering collaboration and growth among its global membership.